The oral, targeted synthetic DMARD (tsDMARD)[2], JAK1 and JAK2 inhibitor baricitinib (Olumiant) is a novel small molecule[1] that is approved in the EU[3] and Japan[4] for the treatment of adults with rheumatoid arthritis RA (moderate or severe active[3]), who responded ...
Baricitinib CAS Number 1187594-09-7 Chemical & Physical Properties [ Density ]: 1.6±0.1 g/cm3 [ Boiling Point ]: 707.2±70.0 °C at 760 mmHg [ Molecular Formula ]: C16H17N7O2S [ Molecular Weight ]: 371.417 [ Flash Point ]: 381.5±35.7 °C [ Exact Mass ]: 371.116455 [ PSA ]: ...